Abstract -This lecture will comprise a review of the state of the art of both academic and industrial aspects of carotenoid research: 1. The present research frontiers of carotenoid synthesis. 2. The future trends and opportunities in the field. 3. The resources needed to explore and go beyond these frontiers. The more important methodologies used in total and partial synthesis will be discussed, including catalysis and organometallic chemistry as well as technical realization, safety, ecology and economy of processes. Where appropriate, biological aspects, such as biosynthesis, biocatalysis, fixed enzymes and organisms, biotechnology and molecular biology will be dealt with. In this context, some more critical questions will be asked concerning e.g.: the future of chemical synthesis, the implementation of biocatalysis, the application of molecular biology to process development, etc. Moreover, the now historic visions and milestones that lead the way to some of the more important ROCHE carotenoid products will be discussed, including my personal views and reflections. Finally, some recent contributions from our laboratories will be presented.
INTRODUCIION
According to the Oxford Dictionary (ref. l), one can read that reflection is defined as meditation, recollection of a thing or reflecting on a person.
Following this line of thought, a very beautiful oil painting by Edvard Munch, named "Summernight" (Inger at the beach) (ref. 2), in my opinion, best depicts the mood needed for reflecting on one of the most important topics treated in this Symposium.
On the other hand, one can take some time at the end of the day to go back over it in the mind, relishing what went wrong, fashioning it into a prelude for tomorrow, as to the Devil's New Dictionary (ref.
3).
Thus reflecting on the past three decades, I can say that not much went wrong; far from it. One of the highlights was the Trondheim Symposium in 1966 (ref. 4), a most memorable occasion. The section on Total Synthesis comprised lectures by 0. Isler, B.C.L. Weedon, T. Kralt, U. Schwieter, J.D. Surmatis and the present author, who as a greenhorn in the field, had the privilege to present the first total synthesis of rhodoxanthin (ref. 5) and who cannot help reminiscing about those early days. From then on a series of very successful symposia took place at three-year intervals up to the present 10th Anniversary Symposium.
Listening to my favourite poet (ref. 6): "Drei Jahr ist eine kurze Zeit, und, Gott! das Feld ist gar zu weit.", it is obvious that I have to obey Voltaire's order: "If you wish to converse with me, confine your terms". Thus, I am forced to define the topics in the field of carotenoid synthesis I want to discuss with you: 1. The present research frontiers. 2. The future trends and opportunities and 3. The resources needed to cross these frontiers.
Of course, I shall include my personal views and reflections. So this presentation will not be a highly scientific progress report but rather an almost philosophical contemplation.
SYNTHESIS
Defining the term synthesis, we should not only consider total synthesis, but also partial and biomimetk synthesis, chemical catalysis, biocatalysis, fermentation and cell culture.
I agree that today romance in carotenoid synthesis has diminished -some say only nostalgic feelings have remained. In my opinion, however, fascination, beauty and even art in the field have increased. Or was it rather serendipity? If you define serendipity as an aptitude to make fortunate discoveries accidentally (ref. l), then you have the definition of making an invention. But that is not enough! Vision is the headline of the present! Not illusion! We must set the milestones, if you define them as significant or important events in the history of a person or a thing (ref. 1).
Of course, it is an old concept. It was followed by Dr. 0. Isler from the very beginning! He always let us have a share in his visions, his imaginative contemplations, which he finally realized! And he also set the milestones for future activities. His philosophy was both simple and very modem -although overemphasized today: You have to have a goal, you have to be original and creative, you have to submit your expertise and secure the resources. Of course, you have to supervise the results and, most importantly, realize them.
For realization, we need resources, and the methodologies at our disposal at present are the following: Wittiflorner reactions, JulidOtera reactions, Grignarwef reactions, Lindlar partial hydrogenations, oxidations, enol ether condensations, vinyl type organometallic additions (Schlosser, Duhamel), aldol condensations, hydrocarbonylations.
Apart from some interesting variations of the Julia type and organometallic reactions, I consider this state of the art totally inadequate for the future. Therefore, it is important for both academia and industry to invest heavily in the exploration of new, efficient, economic and ecologically acceptable methodologies.
Rhodoxanthin
As mentioned before, my first task at ROCHE was to make rhodoxanthin (Fig. l) , the red pigment of Tarols L., one of the yew tree species, of the fish w, of several fungi and of bird feathers, readily available in g-amounts for testing. As a starting material I decided to use the so-called Cl8-ketone which I had received from my colleague and friend U. Schwieter. Unfortunately, I was unable to realize my goal although I had exactly followed the instructions given in a former ROCHE patent (ref. 7). Fig. 1 . Rhodoxanthin and some important building units I was, however, consoled by John Dewey who stated that "we only think when we are confronted with a problem". I had not considered thoroughly enough the following three points: 1. How to prepare efficiently the desired end group beforehand, 2. how to choose and prepare a suitable central unit and 3. how to combine the end group with the central unit. However, we quickly reactivated an old concept, namely to use small cyclic building units which already possess the desired oxygen function together with the correct stereochemistry and optical purity. Thus for rhodoxanthin we chose the first Cpunit and for zeaxanthin and astaxanthin the remaining three ones as will be discussed in the following sections ( Fig. 1) .
O f course suitable central units are required, and the most important one proved to be the Clo-dialdehyde (refs. 8-11) out of a choice of many others. Finally, by employing suitable C14-(ref. 5 ) and Ciyunits (ref. 12), we succeeded in making multigram amounts of rhodoxanthin and even in developing an efficient technical synthesis (ref. 12). We were able to cross the borderline which encouraged us to proceed with more fastidious goals.
As expected, the (all-@-isomer is not the only isomer existing (ref. 13). Most interestingly, Matsuno and coworkers (ref. 14) were able to characterize the (all-& the ( 6 a -and the (6Z,6'Z)-isomer from the fish Tila?-. Moreover, Schiedt and Bischof (ref. 15) were able to detect a 1:2:l-mixture of these isomers in egg yolk after administration of the (all-@-compound to the laying hen.
zeaxanthin So we immediately set out to invent a procedure to convert rhodoxanthin into another important pigment, namely zeaxanthin (ref. 16). As expected, we obtained a 1:2:l-mixture of the (3B,3'B)-, (3&,3'S; meso)-and (3&3'S)-isomers. It is important to note that we now have a method at hand to make two naturally occurring pigments by only a few consecutive steps.
Of course, when Columbus on his first visit to Cuba in 1492 was given a strange plant called maize (meaning "vegetable of life") by the native Arawaks (ref. 17) , nobody cared about zeaxanthin and its stereochemical complexity. Not until 1969 when the absolute configuration of zeaxanthin was established by Weedon and co-workers (ref. 18), and in 1983, when Ruttimann and co-workers (ref. 19) had shown that and other plant sources exclusively contain the (3B,3'B)-isomer. However, in 1985, Schiedt and co-workers (ref. 20) and in 1986 Matsuno and co-workers (ref. 14,21) were able to detect all three optical isomers of zeaxanthin in rainbow trout, fish, shrimp and turtle. Thus, (3B,3'B)-, (3&,3'S;mesn)-and (3S,3'S)-zeaxanthin are now proven to be natural products. Today, in the mid-l990s, when reflecting on our early efforts, I am inclined to admit that an approach based on the biosynthesis of zeaxanthin might be a promising alternative. As was demonstrated by Britton and co-workers in 1977 (ref. 25-26) , lycopene is smoothly cyclized to give B-carotene which is then regioand stereoselectively hydroxylated. The great potential of molecular biology in this area has already been recognized (refs. 27-29) .
Astaxanthin
It was in the mid 197Os, when stereochemistry really claimed its right. We were forced to reflect on chirality, optical activity and symmetry, such as C1, C2 and S2. Further, we were confronted with systems such as AA, ABC and ABBA. Zeaxanthin and astaxanthin both belong to the AA-system (ref. 30) whereas the ABCsystem is true for lutein (ref. 31). The ABBA-system of tunaxanthin causes the existence of ten optical isomers, which were all synthesized more than ten years ago (ref. 31) .
With regard to astaxanthin, a special history supports the development of this most interesting pigment. The exciting milestones that led to the commercialization of this cmtenoid were already expertly reported at the Boston meeting in 1987 by Bernhard (ref. 32) . Today I should like to add some personal views and reflections.
Thus I shall never forget a discussion with Dr. 0. Isler in the early 1970s, when he exclaimed: "You should not forget, astaxanthin could become a business. But we need g-amounts for testing, and fast!" Confronted with this assignment, I fist felt rather uneasy, but later we thought: if prawn were able to synthesize astaxanthin from D-carotene (ref. 33), why should we not be able to do so without enzymes? In fact, astaxanthin was first prepared from crustaxanthin as early as 1967 by Leftwick and Weedon (ref. 34) , and it was obvious to make use of their approach. So when Kienzle (ref. 35 ) and later Hodler (ref. 36 ) took over, they quickly succeeded in preparing astaxanthin in 7 % and 20 % yield, respectively. Thus, the problem was solved rather quickly and the material provided for preliminary investigations. However, for making the multi-kg amounts required for extended studies, partial synthesis was not the method of choice. We had reached the borderline. Moreover, partial synthesis produced a 1:2: l-mixture of the (3S,3'S)-, (3S,3'B;mesn)-and (3B,3'B)-isomers as could readily be detected by the remarkable HPLCmethod developed by Vecchi and Miiller (ref. 37) .
We therefore decided to develop a total synthesis aiming at ( (Fig. 3) to introduce the desired 4-oxo-group. Moreover, the statement often put forward by experts that astaxanthin "racemized" rather fast, was proved wrong by a deuterium-exchange experiment as suggested by Schmid (ref. 39): Kienzle was able to show that no deuterium was incorporated a to the hydroxyl group. This finding was the starting signal for our activities, and in 1976 the first total synthesis of What is the impact of catalvsis? Some experts say: the future will be a catalytic one only, but they neglect definitions. As Berzelius said in 1836: A catalyst is a substance which facilitates a chemical reaction, and which itself undergoes no permanent change. Thus a catalyst can very well be used in equimolar amounts if it can be recycled.
The impact of orpanometallic chemistry will be great, and the present developments in the field are already quite encouraging. Do we need patents? Of course we do, for both industrial and academic institutions. Otherwise any commercially applicable compound, process or formulation could be used by a competitor free of charge, which would mean a serious set-back of progress in numerous important research fields.
What is the correct definition for the term natural? Is it good for a product extracted from natural sources only? May we also include a biotechnically produced carotenoid? How about metabolites? The dilemma can be solved by accepting the definition recently suggested by Liaaen-Jensen (ref. 45): Carotenoids biosynthesized de novo from small carbon units and metabolic products of such carotenoids are considered as natural.
Consequently, the term nature-identical must equal natural, provided we deal with pure compounds possessing identical structures.
The use of @)-isomers is not yet quite clear -are they artifacts? What is an artifact? There are still some contradictory opinions left, but as pointed out by there can be no doubt that welldefined a-isomers, such as ( 9 a -and (13a-0-carotene are natural products. In order to be able to study the chemical and biological behaviour of these compounds more closely, we decided to make these compounds readily available by total synthesis (ref. 46) . Surprisingly, the pure crystalline compounds proved to be quite stable.
Not quite unexpected, the relative provitamin A activity of these isomers compared to the (all-acompound proved to be rather low as determined by my colleague and friend H. Weiser (ref. 47) . Thus (9Z)-B-carotene exhibits only 25 %, the (13Z)-compound 42 % of the activity of (all-a-8-carotene. A low biopotency of (9)-Bcarotene has already been reported by .
The (9Z)-and (13Z)-isomers of astaxanthin needed for registration purposes were prepared by Pdcatalysed isomerization of the (all-a-compound followed by chromatography, HPLC-separation and crystallization (ref. 49) . This task proved much more difficult than with 8-carotene.
In the C2o-series, two i m ortant a)-isomers deserve mentioning: (132)-and (9Z)-retinoic acid. The first activates the nuclear receptor . Both compounds can be considered as metabolites of B-carotene (ref. 53) .
A similar situation is observed with pDtical isomers . Until recently, (3B, 3'S; as well as (3S,3'S)-and (3B,3'S;&-zeaxanthin (refs. 14,20-21) To the customer, we have to offer the pure enantiomer, if nature produces only one, because the others might be inactive or harmful and therefore must be considered like any other impurity. The optical purity of the synthetic enantiomer must at least be the same as that of the natural compound, or better. (Fig. 4) , readily obtained from a-ionone, was oxidized to 4-oxo-5,6-epoxy-D-ionone, which on treatment with acetic acid/acetic anhydride smoothly afforded the desired Clg-building unit (ref. 55). Concerning the mechanism of this transformation, an enol of the type shown could be considered as an intermediate.
2. As a second example, an interesting synthesis of a new optically active C10-unit, useful for the construction of crustaxanthin isomers, is presented: The hydroxy aldehyde on the upper left (Fig. 5 ) was readily epoxidized to give the corresponding epoxide which was smoothly transformed into the desired Ciocrustaxanthin unit (ref. 56) . Depending on the stereochemistry of the starting hydroxy aldehyde and the type of epoxidation, all optical isomers of crustaxanthin may be synthesized if desired. 3. Epoxidation of (3JQ-3-hydroxy-B-ionone (Fig. 6 ) gave a mixture of epoxy ketones which could be readily separated. Subsequent oxidation and epoxide ring opening then led to the pure enantiomeric (+)-(6S)-and 3. Hydrogenation: Improvement of catalytic partial and asymmetric hydrogenations, continuous and selective performance, e.g. with polyenyne systems, trisubstituted double bonds and carbonyl compounds. 4. Oxidation: Invention of new catalytic, regio-and stereoselective oxidation reactions, e.g. direct allylic oxidations, direct asymmetric hydroxylations. 5. a-Isomerizafion: Development of new, catalytic, regio-and stereoselective isomerizations, e.g. kinetically controlled catalytic transformation of (all-B-&carotene into (9Z)-&carotene, regioselective rearrangement of double bonds, e.g. a-ionone = B-ionone, a-isophorone = B-isophorone. 
